1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation

Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation

  1. venkecske
    J. W. Coe et al.

    Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation
    Journal of Medicinal Chemistry, 2005, 48(10), 3474-77.

    A3A or 2,3,4,5-tetrahydro-1,5-methano-1H-3-benzazepine is a key synthetic intermediate for this medicine. Based on its structural similarity to benzomorphans A3A can have opioid-like effects.
Tags: